Ptc Therapeutics

PTCTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$6.119 B

$73.31 +3.47%

Close of 7 Aug 2026

Revenue

$1.73B

#1228 by revenue

Earnings

$683.0M

#510 by earnings

Shares outstanding

83,460,802

Latest filing cover page

P/E ratio

9.0

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#50ErascaERAS$6.30B
#51Xenon PharmaceuticalsXENE$6.12B
#52Ptc TherapeuticsPTCT$6.12B
#53Dianthus TherapeuticsDNTH$6.09B
#54Kiniksa Pharmaceuticals InternationalKNSA$5.93B

Where these numbers come from

Share counts and financials for Ptc Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.